3 recruiting, 1 active not recruiting, 1 completed, 1 terminated. 3 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Completed 1 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Localized Breast Carcinoma: new trials by email Literature Review of Localized Breast Carcinoma trials Research Report on Localized Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors Best Practice, Patient Navigation, Referral - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 330 | 2026-12-09 | 2026-10-23 |
| A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial Starch, Potato - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Recruiting | University of Michigan Rogel Cancer Center | 20 | 2026-04-22 | 2026-04-24 |
| Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial Biospecimen Collection, Fezolinetant, Placebo Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Terminated | University of Michigan Rogel Cancer Center | 9 | 2024-10-31 | 2026-05-06 |
| Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery Lymphedema Management, Questionnaire Administration, Adjuvant breast radiation therapy - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Recruiting | University of Southern California | 50 | 2024-05-24 | 2026-06-05 |
| Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer Best Practice, Informational Intervention, Medical Device Usage and Evaluation - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Completed | Emory University | 33 | 2021-10-22 | 2025-06-17 |
| Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer Berzosertib, Biospecimen Collection, Quality-of-Life Assessment - Bilateral Breast Carcinoma, HER2-Negative Breast Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 42 | 2020-09-24 | 2026-07-31 |
Breast Carcinoma In Situ (3) · Breast Neoplasms (2) · Triple Negative Breast Neoplasms (2) · Carcinoma, Intraductal, Noninfiltrating (1)
Neoplasms (6) · Breast Diseases (5) · Neoplasms by Site (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Carcinoma (4) · Carcinoma in Situ (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Breast Neoplasms (3) · Adenocarcinoma (1) · Breast Carcinoma In Situ (1) · Neoplasms, Ductal, Lobular, and Medullary (1)
Practice Guidelines as Topic (2) · Radiotherapy (2) · Specimen Handling (2) · Standard of Care (2) · Patient Navigation (1) · Radiation (1) · Referral and Consultation (1) · Starch (1) · berzosertib (1) · fezolinetant (1)
University of Michigan Rogel Cancer Center (2) · Emory University (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · University of Southern California (1)
United States (6)
Bridget A Oppong, MD, MPH (1) · Ilana Graetz, PhD (1) · May L Tao, MD (1) · Norah L Henry (1) · Norah L Henry, M.D. (1) · Robert W Mutter (1)
P30CA014089 (1), P30CA138292 (1), UM1CA186686 (1), UM1CA186709 (1)